184 related articles for article (PubMed ID: 34880202)
1. Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in Breast Cancer.
Yi W; Shen H; Sun D; Xu Y; Feng Y; Li D; Wang C
Med Sci Monit; 2021 Dec; 27():e934522. PubMed ID: 34880202
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
4. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.
Chen B; Lu X; Zhou Q; Chen Q; Zhu S; Li G; Liu H
PLoS One; 2023; 18(8):e0290031. PubMed ID: 37582104
[TBL] [Abstract][Full Text] [Related]
5. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
Zhang C; Ren X; Liu Z; Tu C
BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Prognostic Potentials of Long Noncoding RNA ELF3-AS1 in Glioma Patients.
Mei JC; Yan G; Mei SQ
Dis Markers; 2020; 2020():8871746. PubMed ID: 33014189
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Chen T; Zhu C; Wang X; Pan Y
Can J Gastroenterol Hepatol; 2021; 2021():8323487. PubMed ID: 34336727
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
Yang J; Wu W; Wu M; Ding J
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
[TBL] [Abstract][Full Text] [Related]
11. Long non coding RNA SLC26A4-AS1 exerts antiangiogenic effects in human glioma by upregulating NPTX1 via NFKB1 transcriptional factor.
Li H; Yan R; Chen W; Ding X; Liu J; Chen G; Zhao Q; Tang Y; Lv S; Liu S; Yu Y
FEBS J; 2021 Jan; 288(1):212-228. PubMed ID: 32255252
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of OTX2-AS1 is Associated With Immune Infiltration and Predicts Prognosis of Gastric Cancer.
Han QL; Cui Z; Wang Q; Pang F; Li D; Wang D
Technol Cancer Res Treat; 2023; 22():15330338231154091. PubMed ID: 36740995
[TBL] [Abstract][Full Text] [Related]
13.
Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma.
Liao C; Wang A; Ma Y; Liu H
Medicine (Baltimore); 2021 Oct; 100(40):e27473. PubMed ID: 34622876
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
Contreras-Espinosa L; Alcaraz N; De La Rosa-Velázquez IA; Díaz-Chávez J; Cabrera-Galeana P; Rebollar-Vega R; Reynoso-Noverón N; Maldonado-Martínez HA; González-Barrios R; Montiel-Manríquez R; Bautista-Sánchez D; Castro-Hernández C; Alvarez-Gomez RM; Jiménez-Trejo F; Tapia-Rodríguez M; García-Gordillo JA; Pérez-Rosas A; Bargallo-Rocha E; Arriaga-Canon C; Herrera LA
J Mol Diagn; 2021 Oct; 23(10):1306-1323. PubMed ID: 34358678
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs.
Shi GJ; Zhou Q; Zhu Q; Wang L; Jiang GQ
J Clin Lab Anal; 2022 Jun; 36(6):e24384. PubMed ID: 35441740
[TBL] [Abstract][Full Text] [Related]
17. Expression of lncRNA FGD5-AS1 correlates with poor prognosis in melanoma patients.
Gao Y; Zhu H; Mao Q
J Gene Med; 2020 Dec; 22(12):e3278. PubMed ID: 32997827
[TBL] [Abstract][Full Text] [Related]
18. Overexpression and Clinicopathological Correlation of Long Noncoding RNA TMPO-AS1 in Colorectal Cancer Patients.
Mohammadrezakhani H; Baradaran B; Shanehbandi D; Asadi M; Hashemzadeh S; Hajiasgharzadeh K; Safaralizadeh R
J Gastrointest Cancer; 2020 Sep; 51(3):952-956. PubMed ID: 31768869
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of lncRNA SLC26A4-AS1 inhibits papillary thyroid carcinoma progression through recruiting ETS1 to promote ITPR1-mediated autophagy.
Peng D; Li W; Zhang B; Liu X
J Cell Mol Med; 2021 Sep; 25(17):8148-8158. PubMed ID: 34378314
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
Zhong P; Hua H; Chen S; Zhu Z; Xie F
Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
